Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares China Large-Cap ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while iShares China Large-Cap ETF trades at $33.87 (market cap $3.90B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 12.7× iShares China Large-Cap ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| EW | FXI | |
|---|---|---|
Market Cap | $49.44B | $3.90B |
Volume | 3,508,027 | 16,526,479 |
Sector | Health | — |
52-Week High | $95.18 | $41.08 |
52-Week Low | $72.65 | $31.59 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 149 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FXI (iShares China Large-Cap ETF) trades at $33.42, down 1.04% with a bearish technical outlook. The ETF shows compelling valuation at half the S&P 500's P/E ratio with a 1.98% yield, but faces headwinds from China's economic challenges and geopolitical tensions. Recent corporate profit growth of 26% in Q2 2026 provides fundamental support, though weak momentum persists amid global trade concerns.
The ETF offers diversification value and valuation appeal but carries significant political and economic risks. China's industrial overcapacity and weak domestic consumption create volatility, while U.S.-China relations remain a key variable. Institutional interest focuses on long-term value despite near-term bearish technical signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
